Skip to content
KPketaminepath

Mental Health Policy

Articles tagged with “Mental Health Policy”

1 article
FDA Clears NMDA Drug for Alzheimer's Agitation — What It Means for Ketamine Patients — axs fda approval alzheimer disease 2026

FDA Clears NMDA Drug for Alzheimer's Agitation — What It Means for Ketamine Patients

The FDA approved Axsome's AXS-05 for Alzheimer's-related agitation. Here's what this NMDA antagonist approval means for ketamine therapy patients and the field.

Read
Back to all articles

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.

Contact the site